GlassScriptPhysician profile
John C Booker
NPI 1790769768
$1,770.72
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $846 · 2021: $11.27 · 2023: $20.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $328.41 | 2019-2020 | |
| Amgen INC. | $289.78 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $161.49 | 2019-2020 | |
| Novo Nordisk INC | $154.46 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $137.38 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.13 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $84.71 | 2019-2020 | |
| Amarin Pharma, INC. | $75.76 | 2019-2020 | |
| Eisai INC. | $59.28 | 2020 | |
| Abbvie INC. | $53.16 | 2019-2020 | |
| Allergan, INC. | $50.86 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.58 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.99 | 2020 | |
| Abbott Laboratories | $20.28 | 2020 | |
| Sanofi Pasteur INC. | $19.23 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $18.44 | 2020 | |
| Zyla Life Sciences, INC. | $18.35 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.10 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.01 | 2019 | |
| Glaxosmithkline, LLC. | $13.49 | 2020 | |
| Shire North American Group INC | $12.33 | 2019 | |
| Pfizer INC. | $11.50 | 2019 | |
| Astellas Pharma US INC | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Booker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.